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The colonization pattern of intestinal microbiota during childhood may impact health later in life, but
children older than 1 year are poorly studied. We followed healthy children aged 1–4 years (n= 28) for
up to 12 months, during which a synbiotic intervention and occasional antibiotics intake occurred,
and compared them with adults from the same region. Microbiota was quantified with the HITChip
phylogenetic microarray and analyzed with linear mixed effects model and other statistical
approaches. Synbiotic administration increased the stability of Actinobacteria and antibiotics
decreased Clostridium cluster XIVa abundance. Bacterial diversity did not increase in 1- to 5-year-old
children and remained significantly lower than in adults. Actinobacteria, Bacilli and Clostridium
cluster IV retained child-like abundances, whereas some other groups were converting to adult-like
profiles. Microbiota stability increased, with Bacteroidetes being the main contributor. The common
core of microbiota in children increased with age from 18 to 25 highly abundant genus-level taxa,
including several butyrate-producing organisms, and developed toward an adult-like composition. In
conclusion, intestinal microbiota is not established before 5 years of age and diversity, core
microbiota and different taxa are still developing toward adult-type configuration. Discordant
development patterns of bacterial phyla may reflect physiological development steps in children.
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Introduction
Numerous studies have identified associations
between aberrant composition of microbiota in
children and diseases including atopic diseases,
autism, obesity, Crohn´s disease, celiac disease and
food allergies (Kalliomäki et al., 2008; Cucchiara
et al., 2009; Frank et al., 2011; Cheng et al., 2013;
Azad et al., 2014; Nylund et al., 2015; Toh and Allen-
Vercoe, 2015). Decreased diversity and richness of
microbiota has been linked to several disorders
(Turnbaugh and Gordon, 2009; Verdam et al., 2013;
Nylund et al., 2015). For instance, the diversity of
microbial community and the abundance of butyrate-
producing bacteria correlate negatively with the
severity of atopic eczema in young children (Nylund
et al., 2015). Furthermore, reduced diversity and
Bacteroidetes/Firmicutes ratio is associated with obe-
sity (Ley et al., 2006; Turnbaugh and Gordon, 2009;
Verdam et al., 2013). Importantly, aberrancies in early-
life microbiota development may impact the health
status also later in life (Rautava et al., 2012; Nylund
et al., 2014). For example, low levels of bifidobacteria
in infancy may predispose to overweight at the age of 7
years (Kalliomäki et al., 2008). Understanding of the
microbiota development during childhood is essential
in identifying windows of opportunity to influence the
microbiota development.
The major colonization of gut microbiota begins
during birth, when infants are exposed to extra-
uterine environment. The microbiota development is
affected by a number of factors including genetics,
mode of delivery and gestational age, antibiotic
usage, breast feeding (BF)/formula feeding and
Correspondence: R Satokari, Department of Veterinary Bios-
ciences, Faculty of Veterinary Medicine, University of Helsinki,
P.O. Box 66, Agnes Sjöbergin katu 2, Helsinki, 00014, Finland.
E-mail: reetta.satokari@helsinki.fi
7These authors contributed equally to this work.
8These authors contributed equally to this work.
Received 23 April 2015; revised 31 August 2015; accepted
2 September 2015; published online 2 October 2015
The ISME Journal (2016) 10, 1002–1014
© 2016 International Society for Microbial Ecology All rights reserved 1751-7362/16
www.nature.com/ismej
long-term diet after weaning (Penders et al., 2006;
Grönlund et al., 2007; Dominguez-Bello et al., 2010;
Ladirat et al., 2013; Azad et al., 2014; Nylund et al.,
2014; Olivares et al., 2014; Voreades et al., 2014).
During the colonization process, facultative anaero-
bic bacteria, such as Enterobacteria, are gradually
replaced by anaerobic bacteria, such as the genera
Bifidobacterium, Clostridium and Bacteroides
(Weber and Polanco, 2012; Matamoros et al., 2013;
Arrieta et al., 2014). The major diversification of
microbiota is associated with the introduction of
solid foods at 4–6 months of age (Fallani et al., 2011;
Koenig et al., 2011; Bergström et al., 2014).
When compared with adults or older children, the
infant microbiota has low diversity and the micro-
biota structure is generally unstable and highly
dynamic (Arrieta et al., 2014). In contrast, the gut
microbiota of healthy adults is individual specific
and relatively stable in time (Claesson et al., 2011;
Jalanka-Tuovinen et al., 2011; Rajilić-Stojanović
et al., 2013). Two main phyla, Firmicutes and
Bacteroidetes, constitute over 90% of the microbiota
in healthy adults, followed by Actinobacteria,
Proteobacteria and Verrucomicrobia (Claesson
et al., 2011; Jalanka-Tuovinen et al., 2011; Ringel-
Kulka et al., 2013; Voreades et al., 2014). Although
numerous studies have investigated the composition
and dynamics of the intestinal microbiota in infants
and adults, the gut microbiota of toddler and
pre-school children remains poorly characterized,
representing a missing link in the long-term
dynamics. Several studies have reported that the
microbiota starts to resemble adult-like microbiota
within 2–3 years after birth (Koenig et al., 2011;
Yatsunenko et al., 2012; Bergström et al., 2014), but
differences in the bacterial community structure and
diversity still exist between toddlers and adults
(Ringel-Kulka et al., 2013). It is still not known at
what age the individual-specific adult-like micro-
biota profile is established (Koenig et al., 2011;
Bergström et al., 2014; Nylund et al., 2014). There-
fore, the dynamics of microbiota development as
well as the ‘normal course’ of microbiota develop-
ment after infancy are still poorly understood.
The aim of this longitudinal study was to follow
the development of microbiota during 1 year in order
to investigate whether children’s microbiota convert
to adult-type composition and diversity in young
children at 1–5 years of age, and to evaluate the effect
of a synbiotic intervention on fecal microbiota.
Materials and methods
Subjects
Fecal samples were collected from healthy subjects,
including 28 children (12–48 months) and 23 adults
(21–60 years of age) from North Carolina, USA. The
criteria for selecting the participants are described in
detail in the previous cross-sectional study (Ringel-
Kulka et al., 2013). The demographic characteristics
for both children and adults are compiled in
Supplementary Table 1. The studied adult popula-
tion is culturally relatively homogeneous, with
concerns for their fairly similar diet. All children
participating in the study were attending daycare
centers and therefore during working days received
meals that are compiled according to official nutri-
tional requirements for the age group.
In this follow-up study, stool samples from all
children were sampled at the baseline and continu-
ally during 1 year (see Supplementary Figure 1 for
experimental design). After baseline sampling, the
children entered a synbiotic intervention trial for
4 months (Probiotics: Bifidobacterium animalis
subsp. lactis BB-12, Streptococcus thermophilus
and Lactobacillus bulgaricus and inulin, Placebo:
acidified milk) described in detail previously
(Ringel-Kulka et al., 2015). The children had no
history of treatment with antibiotics within the
previous 4 weeks, and no intentional consumption
of probiotics within 2 weeks before the intervention.
Fecal samples were obtained at baseline, at end of
the intervention, and 2 and 8 months after the
intervention. At the end of the intervention, fecal
samples were obtained from 25 children, 12 samples
from the synbiotic intervention group and 13 from
the placebo group. Furthermore, 20 subjects
provided follow-up samples 2 months after the
intervention and 10 subjects provided follow-up
samples 8 months after the intervention
(Supplementary Table 1a). During the intervention
and follow-up time periods, 11 subjects received
short-term antibiotics treatment for acute infections,
such as ear infections. For each child, a body mass
index (BMI) scaled according to the BMI distribution
in the respective age and gender categories, the
Z-score BMI (zBMI), was determined. All recorded
data are compiled in Supplementary Table 1a.
Ethical considerations
The study was approved by the University of North
Carolina (UNC) Internal Review Board. All adult
subjects and parents/guardians of the children
provided written consent before study participation.
Fecal samples and DNA extraction
The sample collection and preparation has been
described previously (Carroll et al., 2011; Ringel-
Kulka et al., 2013). In short, childrens' fecal samples
were collected at home and returned to the daycare
center following previously described instructions
(Ringel-Kulka et al., 2015). The adult fecal samples
were collected at a visit at UNC clinic or at home.
The samples collected at home were transferred to
daycare center or UNC clinic within 12 h from
defecation in a cooler with ice packs. After collec-
tion, the fecal samples were further transferred in
cooler (+4 °C, in average for 4 h) to UNC laboratory
and frozen at − 80 °C before used for DNA extraction.
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DNA was isolated from feces by modified protocol
of the DNA clean-up Kit (Qiagen DNeasy Blood and
Tissue extraction kit, Qiagen, Valencia, CA, USA),
with mechanical disruption of bacterial cells fol-
lowed by chemical extraction of DNA as previously
described (Carroll et al., 2011). The concentration of
isolated DNA was determined by using a Nanodrop
spectrophotometer (Thermo Scientific, Asheville,
NC, USA) before phylogenetic microarray analysis.
Bacterial phylogenetic microarray analysis
Microbial analysis was performed by using the
phylogenetic HITChip microarray (Agilent, Palo
Alto, CA, USA), which targets the V1 and V6
hypervariable regions of the 16S ribosomal RNA
gene, as described and benchmarked previously
(Rajilić-Stojanović et al., 2009; Ringel-Kulka et al.,
2013). In brief, the 16S ribosomal RNA gene was
amplified from sample DNA, transcribed and
labeled, and then fragmented before hybridization
on the microarray. The signal intensity was quanti-
fied by Agilent Feature Extraction software (version
10.7.3.1) after scanning. Sample-wise normalization
and quality control was performed using in-house
scripts in R statistical software (Lahti et al., 2014).
Samples with high reproducibility (40.95 Pearson’s
correlation
coefficient for technical replicates) were accepted for
further analysis. Min–max algorithm (Bolstad et al.,
2003; Han, 2011) was used to normalize between
samples.
The HITChip bacterial phylogenetic microarray
allows analysis at several taxonomic levels (Rajilić-
Stojanović et al., 2009). In this study, we used the
genus level (L2, defined to consist of phylotypes
having 490% sequence similarity of the 16S RNA
gene) and phylum levels (L1, corresponding to a
bacterial phylum or different Clostridium clusters
within Firmicutes) to analyze microbial composi-
tion. Furthermore, oligo-level data were used to
analyze microbial diversity, richness, evenness and
stability, as described previously (Hill, 1973;
McCune et al., 2002; Satokari et al., 2014). The
diversity, evenness and stability were quantified by
Shannon’s index (Hill, 1973), Pielou’s evenness
index (McCune et al., 2002) and Pearson’s correla-
tion coefficient (using consecutive sampling points),
respectively. Richness was quantified as responding
oligos (Satokari et al., 2014). The relative abun-
dances of L1 and L2 phylogenetic groups was
calculated as described previously (Ringel-Kulka
et al., 2013), and compiled in Supplementary
Table 2. The diversity, richness, evenness and
stability of microbiota profiles are summarized in
Supplementary Table 3.
The relative abundance of butyrate-producing
bacteria was obtained by summing the
relative abundances of 10 HITChip genus-level
bacterial groups, which have been reported
to produce butyrate: Clostridium (sensu stricto),
Faecalibacterium prausnitzii et rel., Subdoligranu-
lum variable et rel., Anaerostipes caccae et rel.,
Butyrivibrio crossotus et rel., Coprococcus eutactus
et rel., Eubacterium hallii et rel., Eubacterium rectale
et rel., Roseburia intestinalis et rel. and Eubacterium
cylindroides et rel.
The stabilities were assessed by profile similarity,
measured by Pearson correlation of the oligo-level
profiles between consequent time points for total
microbiota or each phylum. The mean and 95%
confidence intervals were calculated by one sample
t-test (Supplementary Table 4). Phyla with average
Pearson correlation coefficient (cor.) 40.8 were
considered as highly stable, whereas phyla with cor.
between 0.6 and 0.8 were specified as moderate stable,
and phyla with cor.o0.6 were considered to have low
stability (Table 1 and Supplementary Table 4).
Linear mixed effects model
In model fitting, a fully specified linear mixed effects
(LMEs) model (Pinheiro and Bates, 2000) was first
constructed using the R package ‘nlme’ (Pinheiro
et al., 2015). The model included probiotics, anti-
biotics, zBMI, and age as fixed effects and individual
as random effect with autocorrelation structure of
order 1 to take into account the effect of repeated
sampling to explain the outcomes (that is, dependent
variable): stability, diversity, richness and evenness
of total microbial profile and relative abundance of
various phylum-level (L1) and genus-level (L2)
bacterial groups. The fully specified model was then
compared against reduced models where one fixed
effect was removed at a time using likelihood ratio
test. If the test was not significant (P40.05), the
simpler model was accepted. The procedure was
carried out to obtain the final model where no effects
could be removed without significantly affecting the
modeling accuracy. From the final model, P-values
for single effects and interaction terms of the
explanatory variables were extracted. A false dis-
covery rate correction of the P-values was carried out
by Benjamini–Hochberg method (Benjamini et al.,
2001). Significant effects are summarized in
Supplementary Table 5.
Categorized age groups
The significant findings from LME modeling on
relative abundance of bacterial groups were con-
firmed by categorizing the 83 samples from 28
children into four categories according to the age of
the child at sampling: 14–24 months (1–2 years (Y);
10 samples), 25–36 months (2–3 Y; 19 samples), 37–
48 months (3–4 Y; 16 samples) and 49–59 (4–5 Y; 6
samples). In order to avoid the possible confounding
effect of repeated sampling from the same individual
in the same age category, only the first sample for
each child in each category was included in the
analysis. The samples used in the analysis of age
categories are specified in Supplementary Table 1.
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Core microbiota estimation
The shared microbiota among children (so-called
phylogenetic common core; see Salonen et al., 2012)
was analyzed using the categorized age group data.
The oldest age group was omitted from core micro-
biota analysis because of small sample size (six
samples). The composition of core microbiota was
determined as the set of genus-level bacterial groups
that are shared by at least 70% of the subjects and
have a relative abundance of at least 0.1%.
A bootstrap method for estimating core microbiota
was applied (Salonen et al., 2012) using 5000
bootstrap samples. The core microbiota (genus-level
bacterial groups), the mean abundance and fre-
quency (proportion of bootstrap samples where the
group was selected to the core) in each age category
are compiled in Supplementary Table 6. In each age
category (three age categories for children and one
for adults), the inter-individual similarity was calcu-
lated by Pearson correlation between samples.
Statistical analysis
Statistical analysis was carried out in R version
2.15.3 by using the packages ‘stats’ and ‘vegan’
(Oksanen et al., 2015). For the comparison between
children and adults, the division to age groups was
used for assessing total microbiota diversity/rich-
ness/evenness, core microbiota, relative abundance
of phylum-level/genus-level groups, and inter-
individual similarities. The comparison between
different age categories and adults was carried out
by Kruskal–Wallis and Wilcoxon rank-sum tests
(Siegel and Jr, 1988). For all analyses, false discovery
rate corrected P-values below 0.05 were considered
significant.
Results
Temporal effect of synbiotic intervention and
antibiotics on the phylum-level bacterial groups
Overall, age was found to be the major factor
affecting the microbiota profiles in children
(discussed in detail later). The other factors did not
have a drastic effect on the overall microbiota
profiles, but had an effect on the relative abundance
or stability of three phylum-level bacterial groups.
Specifically, the synbiotic supplementation was
found to have a minor effect by increasing the
stability of Actinobacteria as compared with
the placebo group. There was no difference in the
overall abundance of the genus Bifidobacterium
between the intervention groups, although the
probes targeting the administered Bifidobacterium
species showed increased levels after the interven-
tion period in the synbiotic group (data not shown).
Antibiotics were found to decrease the relative
abundance of Clostridium cluster XIVa in the next
sample taken after the course (Supplementary Figure
2a, LME P=0.02). In the following samples after the
cessation of antibiotic use, the abundance differenceTa
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is not significant when compared with the baseline
or the next sample after antibiotic course
(Supplementary Figure 2b). In addition, the stability
of Clostridium cluster I was observed to decline with
antibiotic use.
No significant increase in the diversity of intestinal
microbiota from 1 to 5 years of age
To provide a general view of the temporal changes in
intestinal microbiota, we first evaluated microbiota
diversity, richness and evenness that all showed
high intra-individual variation (Figure 1). To focus
on the temporal development, LME was used to
estimate the effect of age on the diversity while
controlling for the effect of repeated sampling.
Overall, no change in microbiota diversity was
observed in children from 14 to 59 months of
age (corresponding to approximately 1–5 years)
(Figure 1a). Moreover, the microbiota diversity was
significantly (Po0.01) lower in all age categories in
children than in adults (Figure 1). Altogether, it
seems that microbiota diversity, including richness
and evenness, undergo fluctuations during 1–5 years
of age, but there is no developmental trend toward
adult-level diversity. As a technical point, it should
be noted that the diversity indices are calculated
from the HITChip oligo-level data and therefore
cannot be directly compared with those based on
16S ribosomal RNA gene sequencing.
Major intestinal phyla show discordant development
toward an adult-type profile
Although the diversity of microbiota seemed to be at
a child-type, presumably transient stage, a number of
significant changes in both the abundance and
stability of different taxa within the bacterial
community were found. First, the stability of the
bacterial community was found to increase from 1 to
5 years, since the total microbiota profile similarity
between consecutive time points increased with age
(P=0.03 in LME, Figure 2). Second, we observed that
major intestinal phyla are developing toward
adult-type abundancies discordantly (Table 1). For
example, Actinobacteria (Figure 3a), Bacilli and
Clostridium clusters I and IV were all characterized
by child-like abundance levels. However, Clostri-
dium cluster IV showed low stability, whereas
Clostridium cluster I, Actinobacteria and Bacilli
Figure 1 The effect of age on (a) diversity, (b) richness and (c) evenness of microbiota. No significant change is observed for diversity,
richness or evenness during 1–5 years. Left panel: solid line indicates repeated sampling from the same individual. Dashed line indicates
regression fit with LME line (P=NS). Right panel: diversity, richness and evenness plotted in age categories. Samples 1.5 times more than
the upper quartile (third quartile) or less than the lower quartile (first quartile) are denoted by circles. Microbial community is significantly
less diverse (panel a) and rich (b) in all age categories in children than in adults, whereas being less even (c) in the ‘1–2 Y’ and ‘4–5 Y’ age
categories than in adults. Significances were estimated by Wilcoxon rank-sum test, with Benjamini–Hochberg P-value correction.
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had high stability (Table 1, Figures 4 and 5). Within
Actinobacteria, the largest genus Bifidobacterium
had a significantly (P=8.4E–05) higher abundance in
children aged 1–2 Y than in adults and its abundance
did not change significantly from 1 to 5 years
(Supplementary Figure 3). On the other hand, the
abundances of Clostridium cluster XIVa (Supplementary
Figure 4f) and Proteobacteria (Supplementary Figure 4g)
seem to have reached adult-type levels already
during childhood (Table 1, Supplementary Figure
4). However, although the stability of Clostridium
cluster XIVa was still low (mean cor. = 0.50;
Figures 4 and 5h), the stability of Proteobacteria
was moderate (mean cor. = 0.71; Figure 5i). Further-
more, Bacteroidetes (Supplementary Figure 4b), Clos-
tridium cluster III (Figure 3b) and Clostridium cluster
XI (Supplementary Figure 4e) seemed to be developing
toward adult-type profiles, as denoted by significantly
increasing stability or abundance (Table 1). The
increasing abundance of Clostridium cluster III was
not reflected in a significant abundance increase in any
of the individual genus-level groups within the cluster
(data not shown). Finally, Verrucomicrobia, repre-
sented by a single genus Akkermansia, seemed to be
established in abundance already in childhood
(Supplementary Figure 5).
Interestingly, among the different phyla, only the
Bacteroidetes showed a significant increase in
stability from 1 to 5 years (P=0.04; Figure 5c). Thus,
Bacteroidetes seemed to be the main component in
increasing stability of total microbiota profiles.
Within Bacteroidetes, Bacteroides spp. (Supplementary
Figure 6a) contributes to the increasing stability of the
phylum, whereas Prevotella spp. profiles had consistent,
overall high stability in these children (Supplementary
Figure 6b).
In addition, the similarity of total microbiota
profiles between individuals was assessed by Pear-
son correlation for each age category, with both
qualitative and quantitative estimation. Highest
inter-individual similarity was observed for children
in the 3–4Y group, differing significantly from
the other age groups of children or adults
(Supplementary Figure 7).
Core microbiota starts to shape early in life
To estimate the common core of microbiota in
children and to assess its compositional develop-
ment toward an adult-type core, we subdivided and
analyzed children in three age categories and
compared them with adults. The core microbiota
estimation revealed 18 genus-level (L2) groups for
the 1–2 Y children that belong to four phylum-level
bacterial groups (Figure 6; Supplementary Table 6).
Interestingly, 5 out of the 18 genus-level groups were
found to be butyrate-producing bacteria. The number
of bacterial groups shared between individuals was
found to increase with age, and the common core
microbiota of children in 2–3 Y and 3–4 Y categories
consisted of 23 and 25 genus-level bacterial groups,
respectively. After childhood, Bifidobacterium,
Streptoccus mitis et rel. and Streptococcus bovis et
rel. were replaced by Oscillospira guillermondii
et rel., Butyrivibrio crossotus et rel. and Clostridium
stercorarium et rel. in the common core of adults
(Figure 6). Collectively, the bacterial groups of the
core microbiota constituted 470% of the total
microbiota, and the summarized abundance was
similar in different age categories (Supplementary
Figure 8). The results indicate that core microbiota
Figure 2 Stability of total microbiota in children of 1 to 5 years
old. Stability is assessed as the similarity (Pearson correlation) of
microbiota profiles between consecutive time points. Each point
plotted represents the older age in the pair compared. The time
interval between the first plotted time point and the baseline
sample point is 4 months. The microbiota stability is increasing
significantly with age (LME: P=0.03, slope=0.006 per month).
The model fit is indicated by the dashed line.
Figure 3 Relative abundance of Actinobacteria and Clostridium
cluster III in different age categories. Between 1 and 5 years, the
relative abundances of Actinobacteria (a) do not change (LME:
P=NS), whereas the relative abundance of Clostridium cluster III
(b) increases significantly (LME: P=0.03). The relative abundances
of Actinobacteria (a) in all age categories in children are
significantly higher than that of adults, whereas significant
differences of Clostridium cluster III (b) between children and
adults are observed in the first two age categories: ‘1–2 Y’
(P=0.0008) and ‘2–3 Y’ (P=0.003). Samples 1.5 times more than
the upper quartile (third quartile) or less than the lower quartile
(first quartile) are denoted by circles.
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starts to shape early in life, but its assembly is likely
to undergo changes after childhood.
Butyrate-producing bacteria increase gradually during
childhood
Ten genus-like bacterial groups in the HITChip are
known to produce butyrate. To get insight into the
temporal development of this important functional
group, we summed their relative abundances
together. Remarkably, the relative abundance of
butyrate-producing bacteria was increasing with
age in children (P=0.02 in LME), and their abun-
dance reached similar level to adults before 5 years
of age (Supplementary Figure 9). Moreover, the
number of butyrate-producing bacterial groups was
gradually increasing in the core microbiota
(Figure 6), testifying for the diversification and stable
establishment of this key functional group in healthy
children.
Discussion
The human intestinal microbiota is considered to be
an important factor in determining human health. In
toddlers, both compositional and functional devel-
opment of intestinal microbiota are still not well
described. In this study, we characterized the fecal
microbiota composition of 28 unrelated healthy
children (around 1–5 Y) by repeated sampling
during a period of up to 1 year. The wide range of
sampling ages expanded our observation from
subject-specific patterns to general microbiota devel-
opment trends in children 1–5 years of age.
The children in this study participated also in a
synbiotic intervention, which was found to have
only a minor effect on fecal microbiota—the only
significant effect was that the higher stability of
Actinobacteria in the intervention group. The find-
ing is in agreement with several probiotic interven-
tion studies, where limited changes in overall
structure of fecal microbiota were observed both in
children (Larsen et al., 2011; Nylund et al., 2013) and
in adults (Gerritsen et al., 2011; Kim et al., 2013;
Lahti et al., 2013). The increased stability of
Actinobacteria in the treatment group may have
been caused by inulin, which is known to support
the growth of bifidobacteria, the main group within
the phylum, in the intestine (Veereman, 2007;
Salazar et al., 2014).
The use of antibiotics was found to reduce the
relative abundance of Clostridium cluster XIVa and
the stability of Clostridium cluster I. The result is in
line with previous studies showing that antibiotics
reduce microbiota stability and diversity (Rehman
et al., 2012; Panda et al., 2014). We found that the
abundance of Clostridium cluster XIVa was signifi-
cantly decreased in the next sample after antibiotic
course. There is indication that after cessation of
antibiotics Clostridium cluster XIVa is recovering, as
its abundance is intermediate between the baseline
sample before antibiotics and the next sample after
the antibiotic course (Supplementary Figure 2b).
Thus, the effect of single antibiotic course seems to
be temporal and that at least partial recovery takes
place during the following weeks and months.
Previously, repeated antibiotic courses have
been shown to result in an incomplete recovery of
microbiota (Dethlefsen and Relman, 2011). In
subsequent analysis, the effects of the synbiotic
intervention and antibiotics were taken into account
as covariates when assessing the temporal develop-
ment of microbiota.
The main outcome of this study is that intestinal
microbiota is not fully established in children up to 5
years of age. First, the bacterial diversity is signifi-
cantly lower as compared with adults and it does not
increase significantly from 1 to 5 years of age.
Previously it has been shown that species (opera-
tional taxonomic unit) richness sharply increases
during the first year of life, especially after weaning
(Palmer et al., 2007; Nylund et al., 2013; Yatsunenko
et al., 2012). A recent large-scale study showed that,
from 1–3 years of age, children from both Amazonas
of Venezuela and rural Malawi had an increasingly
diverse microbiota, whereas children from the
United States in this age category did not show a
similar trend (Yatsunenko et al., 2012; Schloss et al.,
2014). Our study expands these findings by studying
a time course and shows that children from the
United States still harbor a significantly less diverse
and less stable microbiota as compared with adults
Figure 4 The stability of phylum-level groups in 1- to 5-year old
children. The boxplot shows the distribution of profile similarities
(Pearson correlation of oligo-level profiles between consecutive
time points) of genus-like taxa with each phylum. The groups with
average similarity o0.6 (indicated with the lower horizontal
dashed line) are considered as low stability groups, whereas
groups with average similarity 40.8 are considered as highly
stable (indicated by the upper horizontal dashed line). The groups
with similarities between 0.6 and 0.8 are considered moderately
stable. Samples 1.5 times more than the upper quartile (third
quartile) or less than the lower quartile (first quartile) are denoted
by circles.
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up to 5 years of age. Therefore, it could be
hypothesized that the western lifestyle may affect
the diversification of intestinal microbiota. A num-
ber of factors, including overly hygienic conditions,
diet and the use of antibiotics, are known to impact
microbiota development in infants (Rautava et al.,
2012; Nylund et al., 2014). We presume that the
children in this study develop a more diverse
microbiota later in life; however, at the same time
we cannot exclude the possibility that their
Figure 5 The development of stability of phylum-level groups in 1- to 5-year-old children. The stability is assessed by similarity of
profiles (Pearson correlation) between consecutive time points from oligo-level data. Each plotted point represents the older age in the pair
compared. The time interval from the first plotted time point to the baseline sample point is 4 months. Samples from the same individual
are connected by solid lines. The development of stability is estimated by LME, and indicated by the dashed line. The stability of
Bacteroidetes increases significantly (c, LME: P=0.04), whereas Clostridium cluster XI shows increasing trend (g, LME: P=0.08) and the
stabilities of other phylum-level groups remain at similar levels at 1 to 5 years of age (a, b, d, e, f, h and i, LME: P=NS).
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microbiota does not reach the same level of diversity
as in earlier generations.
We found that although the bacterial diversity was
at a similar level from 1 to 5 years of age, the
microbiota was undergoing gradual transformations.
For example, the overall microbial profile stability
was increasing, and specific phyla, such as Clostri-
dium clusters III, IV and XI, showed development
toward adult-level abundances. However, we also
observed that Actinobacteria and Bacilli were stably
more abundant in children as compared with adults.
Our results contrast the previous perception that
intestinal microbiota has reached adult-type config-
uration by 3 years of age (Yatsunenko et al., 2012).
Recently, Bäckhed et al. (2015) studied the develop-
ment of microbiota in Swedish children from birth to
1 year of age and found that the cessation of BF
induces a major diversification of the microbiota and
that the microbiota composition at 1 year of age
resembles that of adults. However, some bacterial
groups still showed differences between 1-year-old
children and their mothers (Bäckhed et al., 2015),
which is in line with the results of our study,
showing that microbiota maturation continues after
1–2 years of age. On the other hand, we found
Clostridium cluster XIVa and Proteobacteria to be at
adult-like level already in 1–2 years old children.
Thus, we conclude that major intestinal phyla seem
to develop toward an adult-type abundance and
configuration discordantly, and the microbiota
maturation exceeds 5 years of age.
Actinobacteria, especially bifidobacteria, are typi-
cally found in high quantities in infants (Roger et al.,
2010; Arrieta et al., 2014; Bergström et al., 2014).
A recent large Danish cohort study showed that
the relative abundance of Bifidobacterium spp.
decreased significantly from 9 months to 3 years of
age. However, the levels were not compared with
those in adults (Bergström et al., 2014). BF is known
to be one of the major factors affecting microbiota
composition in infants and supports the bifidobac-
terial population in particular (Nylund et al., 2014).
In our cohort, the time interval between the cessation
of BF and the baseline sampling was on average
21 months. The low number of formula-fed children
(n=4) did not allow reliable comparisons, but we did
not detect significant differences in the abundances
of any genus-level bacterial groups, including
bifidobacteria, between BF and formula-fed children
in baseline samples (data not shown). However,
bifidobacteria remained at a significantly higher
level in children up to 5 years of age as compared
with adults (Supplementary Figure 3). The effect of
the synbiotic intervention in the study cohort is only
minor and does not explain the elevated levels, as
similar effect was detected in both intervention
groups—even during the intervention the bifidobac-
teria levels were not different between the groups.
The observed elevated bifidobacterial levels in early
life are potentially beneficial as previous reports
suggest a protective role of bifidobacteria against
excessive weight gain and neuropsychiatric
disorders in later life (Kalliomäki et al., 2008;
Pärtty et al., 2015).
The overall stability of microbiota was found to
increase over the different age groups over time, that
is, from 1 to 5 years of age. However, the microbiota
similarities, both in short and long term, were still
remarkably lower than previously observed for
western adults by using the same microarray
technique for microbiota assessment (Jalanka-
Tuovinen et al., 2011; Rajilić-Stojanović et al.,
2013; Fuentes et al., 2014; Satokari et al., 2014).
Furthermore, we found that the most predominant
Figure 6 The development of core microbiota#. The asterisk (*) indicates typical infant taxa that are diminished in the adult core. The
taxa of butyrate-producing bacteria are underlined. # For the core microbiota estimation, see text for details.
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groups within Firmicutes, Clostridium clusters XIVa
and IV, had temporally instable profiles, whereas
other major phyla, Actinobacteria, Bacteroidetes,
Proteobacteria, appeared more stable in children. In
adults, all these groups with the exception of
Proteobacteria have been described to be relatively
stable (Faith et al., 2013; Rajilić-Stojanović et al.,
2013). The low stability of Clostridium cluster XIVa
and IV in children implies that the species
assemblies and taxa abundances within these phyla
are still undergoing rearrangements, and thus have
not reached a mature, adult-like status. Interestingly,
among all phyla, Bacteroidetes was the only one that
showed increasing stability, and thus this phylum
and more specifically Bacteroides spp. seem to be
the main contributors to stability increase of total
microbiota profiles. The increasing stability of
Bacteroidetes (that is, Bacteroides spp.) may indicate
that it is developing toward established, individual-
specific species assembly with high stability, as
revealed for adults (Faith et al., 2013; Rajilić-
Stojanović et al., 2013). Further, the highest inter-
individual similarity in 3–4 years children
(Supplementary Figure 7) may result from a more
established microbiota as compared with younger
children, and longer consumption of daycare center
meals. Previously, it has been shown that the gut
microbiota of elderly people alter shortly after
institutionalization, demonstrating the impact of diet
and environment (Claesson et al., 2012). Taken
together, our results show that the maturing intest-
inal ecosystem of children is characterized by
discordant temporal development of bacterial phyla
toward adult-type profiles.
It has been suggested that, despite the highly
individual-specific microbiota profiles, people share
a common subset of relatively highly abundant
bacterial species/groups, the so-called core micro-
biota (Salonen et al., 2012). In this study, a common
core comprising four phylum-level groups (Actino-
bacteria, Bacilli, Clostridium clusters IV and XIVa)
was detected in all child age categories and adults,
which indicates the emergence of core microbiota
already at around 1 year of age. The common core in
children increased with age from 18 to 25 genus-
level taxa and developed toward adult-like composi-
tion. Similar to our results, Vallès et al. (2014)
recently reported the expansion of core microbiota
during childhood. However, Vallès et al. (2014)
reported a much larger core, 49 genera in 13
1-year-old children, which is most likely due to a
different definition of the core as compared with our
study. In the Vallès et al. study, the core includes
genera that are present in all individuals without any
abundance threshold, whereas we applied a thresh-
old of 40.1% of relative abundance and 70%
prevalence of the genus-like groups. We found that
Bifidobacterium spp., S. mitis et rel. and S. bovis et
rel. were replaced by O. guillermondiii et rel.,
B. crossotus et rel. and Cl. stercorarium et rel. in
the adult core. The first mentioned three bacterial
groups are typical infant taxa and present in adults in
much lower quantities, which explains their disap-
pearance from the adult core (Roger and McCartney,
2010; Arrieta et al., 2014; Bergström et al., 2014).
The abundance of butyrate-producing bacteria
was found to increase from 1 to 5 Y, implying the
establishment of an important functional group.
Butyrate serves as an energy source for host
intestinal epithelium cells and upregulates the
expression of tight junction proteins (Ulluwishewa
et al., 2011; Leonel and Alvarez-Leite, 2012; Plöger
et al., 2012), thereby fortifying epithelial barrier
function. Furthermore, butyrate promotes the differ-
entiation and proliferation of regulatory T cells, and
inhibits nuclear factor-kB activation (Leonel and
Alvarez-Leite, 2012; Plöger et al., 2012; Louis et al.,
2014), that is, act as anti-inflammatory agent. Although
butyrate is mostly described to have positive effects, in
an experimental model the improvement of necrotiz-
ing enterocolitis was associated with the decrease of
butyrate (Butel et al., 2002). On the other hand, in
preterm infants the overall number of fecal volatile
organic compounds was found to be reduced in
subjects who developed NEC (Garner et al., 2009).
In summary, our study shows that the human
intestinal microbiota is not established before 5 years
of age in US children: the diversity, core microbiota
and different bacterial phyla are still developing
toward adult-type configuration. The gradual devel-
opment of microbiota may reflect the stepwise
development of host physiology. For example, the
most important cellular components of the gastro-
intestinal immune system are already present in fetal
life (Tourneur and Chassin, 2013), but a newborn
still has immature intestinal mucosal layer, immu-
nological and metabolic functions (Fernandez et al.,
2011; Jakobsson et al., 2014; Levy and Wynn, 2014;
Pichichero, 2014). After a few months, infants are
able to absorb fat-soluble compounds efficiently
because of maturation of bile salt (Fernandez et al.,
2011). Furthermore, the full maturation and activa-
tion of immune system requires the stimulation of
microbiota during many years after birth. For
example, the activity of natural killer cells
normalizes at 4–5 years of age and IgG and IgA
reach adult-like serum levels only at the age of 5–6
years and 10 years, respectively (Jarva and Meri,
2011). The remarkable maturation process of the
gastrointestinal physiology and immunology is likely
to affect the microbiota; and vice versa, microbiota is
likely to be involved in these maturation events
(Maynard et al., 2012). On the other hand, nutritional
requirements keep rather similar from 1 to 6 years of
age (ASPEN Board of Directors and the Clinical
Guidelines Task Force, 2002) and relatively stable
dietary patterns may serve as a stabilizing factor for
the microbiota. In our study, the synbiotic adminis-
tration was found to have minor effects on the fecal
microbiota and because of the intervention trial and
occasional antibiotics use, the study population may
not have been ideal to investigate microbiota
Development of fecal microbiota in young children
J Cheng et al
1011
The ISME Journal
development in controlled environment. On the
other hand, the administration of synbiotics and/or
antibiotics is not rare among western children, and
thus the study represents real-life conditions. Over-
all, we conclude that the maturation of gut micro-
biota exceeds 5 years of age. It can be presumed that
profound changes in the host physiology during
adolescence will further shape the microbiota
toward an individual-specific, mature configuration.
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